Delivery Order SPE2DB25D3021-SPE2DB25FQYHM
Award Date
5/1/25
Potential Completion Date
5/2/25
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $50,838.99, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract to supply 4,567,957,197 units of Humulin R 500 unit/mL Kwikpen 3mL, a diabetes medication. The contract has a firm-fixed price pricing type and a completion date of April 18, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen...
This federal contract award is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML (a type of insulin medication) to the Defense Logistics Agency (DLA). The $2,236.32 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance through February 2024 and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This federal contract award, valued at $11,135.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Humulin R 500 unit/mL KwikPen, a diabetes medication, with a performance period extending through April 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Humulin R 500 Unit/mL Kwikpen 3mL, a specialty diabetes medication. The $20,154.63 firm-fixed-price delivery order has a completion date of December 4, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award is for the delivery of Humulin R 500 Unit/mL Kwikpen 3mL medical products to the Defense Logistics Agency (DLA). The $2,323.14 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $16,084.67, is for the delivery of Humulin R 500 Unit/mL Kwikpen 3mL, a specialty medication used to manage diabetes. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support...
This federal contract award, valued at $4,970.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Humulin R 500 unit/mL Kwikpen 3mL, a diabetes medication. The contract has a firm fixed-price pricing type and an ultimate completion date of April 16, 2025. This award is not designated as a set-aside contract, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, worth $14,279.41, is for the delivery of Humulin R 500 Unit/mL Kwikpen 3mL, a medication used to treat diabetes. The contract is a firm fixed-price delivery order with a completion date of March 6, 2025. There is no set-aside designation for this award. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Humulin R 500 Unit/mL Kwikpen 3mL, a specialty medication used to manage diabetes. The contract has a ceiling value of $1,548.76 and a completion date of March 3, 2025. This is a delivery order contract with a firm fixed price pricing type. The award is not designated with a set-aside...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Humulin R 500 Unit/mL Kwikpen 3mL. The contract has a ceiling value of $2,253.12 and was awarded on September 27, 2022, with a completion date of September 28, 2022. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support...